Somewhere at some point in the future, an unknown casino is going to be built in Europe. The details are obviously extremely vague, but what is certain is that a Canadian pharmaceutical company plans on being a part of it. According to a press release by Easton Pharmaceuticals, the pharma giant has signed a Letter of Intent to be involved in the project that will see a hotel and casino resort be erected.

The announcement indicated that more details regarding the project will be released within the next several weeks after negotiations have been completed. Easton added that it is partnering with a US-based gaming arm of a holding and investment company out of Canada, which is leading the development of the resort.

The project is expected to have a casino with around 50 gaming tables and approximately 1,000 slot machines. It will also feature a 538-room hotel with additional VIP suites, a showroom, retail space and a spa and wellness center. It is supposedly being built in a highly attractive area and is expected to generate over €77 million (US$89 million) in revenue annually.

Evan Karras, Easton Pharmaceuticals’ CEO, said, “This casino and hotel resort project will be a high-end development in an idyllic river location and will be the second Casino Hotel Resort Easton intends to participate in as part of our global expansion plan. It is expected to be one of the most prominent properties when it opens. I am excited for the prospects of having Easton participate in such an incredible opportunity.”